Biofrontera (BFRI) Other Non-Current Liabilities (2020 - 2025)
Biofrontera (BFRI) recorded quarterly Other Non-Current Liabilities of $351000.0 in Q4 2025, down 57.86% quarter-over-quarter from $833000.0 in Q3 2025, and down 71.92% on a YoY basis from $1.3 million in Q4 2024.
Biofrontera (BFRI) Other Non-Current Liabilities (2020 - 2025) Analysis & Trends
Biofrontera's Other Non-Current Liabilities history runs 6 years deep, the most recent figure standing at $351000.0 for Q4 2025.
- In Q4 2025, Other Non-Current Liabilities fell 71.92% year-over-year to $351000.0; the TTM figure through Dec 2025 stood at $351000.0 (down 71.92% YoY), while the FY2025 annual figure was $351000.0, down 71.92% from the prior year.
- Other Non-Current Liabilities was $351000.0 for Q4 2025 at Biofrontera, down from $833000.0 in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $11.7 million in Q1 2024 to a low of $21000.0 in Q4 2022.
- Historically, Other Non-Current Liabilities has averaged $3.3 million across 5 years, with a median of $1.5 million in 2023.
- The sharpest annual moves came in 2022 and 2024: Other Non-Current Liabilities plunged 99.63% in 2022, then surged 48779.17% in 2024.
- A 5-year view of Other Non-Current Liabilities shows it stood at $5.6 million in 2021, then sank by 99.63% to $21000.0 in 2022, then soared by 19947.62% to $4.2 million in 2023, then plunged by 70.31% to $1.2 million in 2024, then slumped by 71.92% to $351000.0 in 2025.
- The last three Other Non-Current Liabilities figures came in at $351000.0 (Q4 2025), $833000.0 (Q3 2025), and $548000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Biofrontera | 8.65 Mn | 2.24 Mn | 14.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 351,000.00 |
| Sep 30, 2025 | 833,000.00 |
| Jun 30, 2025 | 548,000.00 |
| Mar 31, 2025 | 702,000.00 |
| Dec 31, 2024 | 1.25 Mn |
| Sep 30, 2024 | 1.60 Mn |
| Jun 30, 2024 | 921,000.00 |
| Mar 31, 2024 | 11.73 Mn |
| Dec 31, 2023 | 4.21 Mn |
| Sep 30, 2023 | 2.50 Mn |
| Jun 30, 2023 | 1.44 Mn |
| Mar 31, 2023 | 24,000.00 |
| Dec 31, 2022 | 21,000.00 |
| Sep 30, 2022 | 8.95 Mn |
| Jun 30, 2022 | 8.05 Mn |
| Mar 31, 2022 | 4.14 Mn |
| Dec 31, 2021 | 5.65 Mn |
| Sep 30, 2021 | 5.65 Mn |
| Dec 31, 2020 | 62,000.00 |